Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
2.3. Scope Of Study
2.4. Crisis Scenario Analysis
2.4.1. Impact Of Covid-19 On Artificial Intelligence (Ai) In Epidemiology Market
2.5. Major Market Findings
2.5.1. Public-Private Partnership In Ai For Health Infection Prediction & Forecasting
2.5.2. Rising Applications Of Ai In Personalized Medications
2.5.3. Increasing Popularity In Infection Prediction And Forecasting On Cloud-Based Platforms

3. Market Dynamics
3.1. Key Drivers
3.1.1. Early Detection And Surveillance Of Disease Outbreaks
3.1.2. Predictive Modeling To Forecast Disease Trends
3.1.3. Data Availability For Epidemiological Research
3.2. Key Restraints
3.2.1. Privacy And Ethical Concerns Regarding Sensitive Patient Data
3.2.2. Data Quality And Availability Challenges

4. Key Analytics
4.1. Key Market Trends
4.1.1. Advancements In Machine Learning And Data Analytics
4.1.2. Expansion Of Telehealth And Remote Monitoring
4.1.3. Integration Of Ai In Public Health Systems
4.2. Porter’S Five Forces Analysis
4.2.1. Buyers Power
4.2.2. Suppliers Power
4.2.3. Substitutes
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Growth Prospect Mapping
4.4. Market Maturity Analysis
4.5. Market Concentration Analysis

5. Market By Deployment
5.1. On-Premise
5.1.1. Market Forecast Figure
5.1.2. Segment Analysis
5.2. Web-Based
5.2.1. Market Forecast Figure
5.2.2. Segment Analysis
5.3. Cloud-Based
5.3.1. Market Forecast Figure
5.3.2. Segment Analysis

6. Market By Application
6.1. Infection Prediction & Forecasting
6.1.1. Market Forecast Figure
6.1.2. Segment Analysis
6.2. Disease & Syndromic Surveillance
6.2.1. Market Forecast Figure
6.2.2. Segment Analysis
6.3. Monitoring Population Health & Incidence/ Prevalence
6.3.1. Market Forecast Figure
6.3.2. Segment Analysis

7. Market By End Use
7.1. Government & State Agencies
7.1.1. Market Forecast Figure
7.1.2. Segment Analysis
7.2. Research Labs
7.2.1. Market Forecast Figure
7.2.2. Segment Analysis
7.3. Pharmaceutical & Biotechnology Companies
7.3.1. Market Forecast Figure
7.3.2. Segment Analysis
7.4. Healthcare Providers
7.4.1. Market Forecast Figure
7.4.2. Segment Analysis

8. Geographical Analysis
8.1. North America
8.1.1. Market Size & Estimates
8.1.2. North America Artificial Intelligence (Ai) In Epidemiology Market Drivers
8.1.3. North America Artificial Intelligence (Ai) In Epidemiology Market Challenges
8.1.4. Key Players In North America Artificial Intelligence (Ai) In Epidemiology Market
8.1.5. Country Analysis
8.1.5.1. United States
8.1.5.1.1. United States Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.1.5.2. Canada
8.1.5.2.1. Canada Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.2. Europe
8.2.1. Market Size & Estimates
8.2.2. Europe Artificial Intelligence (Ai) In Epidemiology Market Drivers
8.2.3. Europe Artificial Intelligence (Ai) In Epidemiology Market Challenges
8.2.4. Key Players In Europe Artificial Intelligence (Ai) In Epidemiology Market
8.2.5. Country Analysis
8.2.5.1. United Kingdom
8.2.5.1.1. United Kingdom Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.2.5.2. Germany
8.2.5.2.1. Germany Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.2.5.3. France
8.2.5.3.1. France Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.2.5.4. Italy
8.2.5.4.1. Italy Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.2.5.5. Spain
8.2.5.5.1. Spain Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.2.5.6. Rest Of Europe
8.2.5.6.1. Rest Of Europe Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.3. Asia-Pacific
8.3.1. Market Size & Estimates
8.3.2. Asia-Pacific Artificial Intelligence (Ai) In Epidemiology Market Drivers
8.3.3. Asia-Pacific Artificial Intelligence (Ai) In Epidemiology Market Challenges
8.3.4. Key Players In Asia-Pacific Artificial Intelligence (Ai) In Epidemiology Market
8.3.5. Country Analysis
8.3.5.1. China
8.3.5.1.1. China Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.3.5.2. Japan
8.3.5.2.1. Japan Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.3.5.3. India
8.3.5.3.1. India Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.3.5.4. South Korea
8.3.5.4.1. South Korea Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.3.5.5. Australia & New Zealand
8.3.5.5.1. Australia & New Zealand Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.3.5.6. Rest Of Asia-Pacific
8.3.5.6.1. Rest Of Asia-Pacific Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.4. Rest Of World
8.4.1. Market Size & Estimates
8.4.2. Rest Of World Artificial Intelligence (Ai) In Epidemiology Market Drivers
8.4.3. Rest Of World Artificial Intelligence (Ai) In Epidemiology Market Challenges
8.4.4. Key Players In Rest Of World Artificial Intelligence (Ai) In Epidemiology Market
8.4.5. Regional Analysis
8.4.5.1. Latin America
8.4.5.1.1. Latin America Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities
8.4.5.2. Middle East & Africa
8.4.5.2.1. Middle East & Africa Artificial Intelligence (Ai) In Epidemiology Market Size & Opportunities

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Business Expansions & Divestitures
9.2. Company Profiles
9.2.1. Alphabet Inc
9.2.1.1. Company Overview
9.2.1.2. Product List
9.2.1.3. Strengths & Challenges
9.2.2. Bayer Healthcare
9.2.2.1. Company Overview
9.2.2.2. Product List
9.2.2.3. Strengths & Challenges
9.2.3. Cardiolyse
9.2.3.1. Company Overview
9.2.3.2. Product List
9.2.3.3. Strengths & Challenges
9.2.4. Cerner Corporation
9.2.4.1. Company Overview
9.2.4.2. Product List
9.2.4.3. Strengths & Challenges
9.2.5. Cognizant
9.2.5.1. Company Overview
9.2.5.2. Product List
9.2.5.3. Strengths & Challenges
9.2.6. Eclinical Works Inc
9.2.6.1. Company Overview
9.2.6.2. Product List
9.2.6.3. Strengths & Challenges
9.2.7. Epic Systems Corporation
9.2.7.1. Company Overview
9.2.7.2. Product List
9.2.7.3. Strengths & Challenges
9.2.8. Intel Corporation
9.2.8.1. Company Overview
9.2.8.2. Product List
9.2.8.3. Strengths & Challenges
9.2.9. Komodo Health
9.2.9.1. Company Overview
9.2.9.2. Product List
9.2.9.3. Strengths & Challenges
9.2.10. Meditech
9.2.10.1. Company Overview
9.2.10.2. Product List
9.2.10.3. Strengths & Challenges
9.2.11. Microsoft Corporation
9.2.11.1. Company Overview
9.2.11.2. Product List
9.2.11.3. Strengths & Challenges
9.2.12. Predixion Healthcare (Jvion Llc)
9.2.12.1. Company Overview
9.2.12.2. Product List
9.2.12.3. Strengths & Challenges
9.2.13. Sas Institute
9.2.13.1. Company Overview
9.2.13.2. Product List
9.2.13.3. Strengths & Challenges
9.2.14. Siemens Healthineers
9.2.14.1. Company Overview
9.2.14.2. Product List
9.2.14.3. Strengths & Challenges



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Growth Prospect Mapping
Figure 4: Market Maturity Analysis
Figure 5: Market Concentration Analysis
Figure 6: Global Artificial Intelligence (Ai) In Epidemiology Market, Growth Potential, By Deployment, In 2023
Figure 7: Global Artificial Intelligence (Ai) In Epidemiology Market, By On-Premise, 2024-2032 (In $ Million)
Figure 8: Global Artificial Intelligence (Ai) In Epidemiology Market, By Web-Based, 2024-2032 (In $ Million)
Figure 9: Global Artificial Intelligence (Ai) In Epidemiology Market, By Cloud-Based, 2024-2032 (In $ Million)
Figure 10: Global Artificial Intelligence (Ai) In Epidemiology Market, Growth Potential, By Application, In 2023
Figure 11: Global Artificial Intelligence (Ai) In Epidemiology Market, By Infection Prediction & Forecasting, 2024-2032 (In $ Million)
Figure 12: Global Artificial Intelligence (Ai) In Epidemiology Market, By Disease & Syndromic Surveillance, 2024-2032 (In $ Million)
Figure 13: Global Artificial Intelligence (Ai) In Epidemiology Market, By Monitoring Population Health & Incidence/ Prevalence, 2024-2032 (In $ Million)
Figure 14: Global Artificial Intelligence (Ai) In Epidemiology Market, Growth Potential, By End Use, In 2023
Figure 15: Global Artificial Intelligence (Ai) In Epidemiology Market, By Government & State Agencies, 2024-2032 (In $ Million)
Figure 16: Global Artificial Intelligence (Ai) In Epidemiology Market, By Research Labs, 2024-2032 (In $ Million)
Figure 17: Global Artificial Intelligence (Ai) In Epidemiology Market, By Pharmaceutical & Biotechnology Companies, 2024-2032 (In $ Million)
Figure 18: Global Artificial Intelligence (Ai) In Epidemiology Market, By Healthcare Providers, 2024-2032 (In $ Million)
Figure 19: North America Artificial Intelligence (Ai) In Epidemiology Market, Country Outlook, 2023 & 2032 (In %)
Figure 20: United States Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 21: Canada Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 22: Europe Artificial Intelligence (Ai) In Epidemiology Market, Country Outlook, 2023 & 2032 (In %)
Figure 23: United Kingdom Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 24: Germany Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 25: France Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 26: Italy Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 27: Spain Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 28: Rest Of Europe Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 29: Asia-Pacific Artificial Intelligence (Ai) In Epidemiology Market, Country Outlook, 2023 & 2032 (In %)
Figure 30: China Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 31: Japan Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 32: India Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 33: South Korea Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 34: Australia & New Zealand Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 35: Rest Of Asia-Pacific Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 36: Rest Of World Artificial Intelligence (Ai) In Epidemiology Market, Regional Outlook, 2023 & 2032 (In %)
Figure 37: Latin America Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)
Figure 38: Middle East & Africa Artificial Intelligence (Ai) In Epidemiology Market, 2024-2032 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT ? ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY
TABLE 2: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY DEPLOYMENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY DEPLOYMENT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: GLOBAL ON-PREMISE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: GLOBAL ON-PREMISE MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: GLOBAL WEB-BASED MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: GLOBAL WEB-BASED MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: GLOBAL CLOUD-BASED MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: GLOBAL CLOUD-BASED MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: GLOBAL INFECTION PREDICTION & FORECASTING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: GLOBAL INFECTION PREDICTION & FORECASTING MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: GLOBAL DISEASE & SYNDROMIC SURVEILLANCE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: GLOBAL DISEASE & SYNDROMIC SURVEILLANCE MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 16: GLOBAL MONITORING POPULATION HEALTH & INCIDENCE/ PREVALENCE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: GLOBAL MONITORING POPULATION HEALTH & INCIDENCE/ PREVALENCE MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 18: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY END USE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 19: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY END USE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 20: GLOBAL GOVERNMENT & STATE AGENCIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 21: GLOBAL GOVERNMENT & STATE AGENCIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 22: GLOBAL RESEARCH LABS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 23: GLOBAL RESEARCH LABS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 24: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 25: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 26: GLOBAL HEALTHCARE PROVIDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 27: GLOBAL HEALTHCARE PROVIDERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 28: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 29: GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 30: NORTH AMERICA ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 31: NORTH AMERICA ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 32: KEY PLAYERS OPERATING IN NORTH AMERICA ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET
TABLE 33: EUROPE ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 34: EUROPE ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 35: KEY PLAYERS OPERATING IN EUROPE ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET
TABLE 36: ASIA-PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 37: ASIA-PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 38: KEY PLAYERS OPERATING IN ASIA-PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET
TABLE 39: REST OF WORLD ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 40: REST OF WORLD ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 41: KEY PLAYERS OPERATING IN REST OF WORLD ARTIFICIAL INTELLIGENCE (AI) IN EPIDEMIOLOGY MARKET
TABLE 42: LIST OF MERGERS & ACQUISITIONS
TABLE 43: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 44: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 45: LIST OF BUSINESS EXPANSIONS & DIVESTITURES